Loading...
NPI 1043576663 · Liverpool, NY · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Patrick Oellers is a retina specialist (ophthalmology) physician provider located in Liverpool, New York. This profile covers 21 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Patrick Oellers |
| Address | 200 Greenfield Pkwy |
| City | Liverpool |
| State | NY |
| ZIP | 13088 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | April 9, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.5M |
| Medicaid | $161K |
This provider’s revenue is heavily Medicare‑weighted: total Medicare revenue is $3.5M versus total Medicaid revenue of $161K, indicating Medicare accounts for the overwhelming share of lifetime public-payer receipts and the practice operates with Medicare as its primary payer source. Medicaid is present but small by comparison, so analysis of commercial contracting or Medicare-driven business models will be most relevant.
Revenue concentration is extreme on a few high‑value retinal drugs in Medicare: the precomputed top 3 Medicare codes by revenue account for 82.4% of Medicare receipts, led by J0178 at 68.4%, with J2778 (7.5%) and J2777 (6.5%) making up the remainder of that top-three share. This pattern signals that a large majority of Medicare dollar volume is delivered through a small set of intravitreal biologic injections.
The provider’s procedural mix is consistent with a retina-focused practice that is injection- and imaging-centered: high use of intravitreal drug codes (J0178, J2778, J2777) combined with substantial imaging under 92134 and frequent injection procedure 67028 indicate routine management of retinal diseases requiring repeated injections and retinal imaging monitoring. Surgical retina codes such as 67042 and 67036 appear but represent a small share of revenue, reinforcing that outpatient injection and imaging services—not frequent major surgery—drive the business model.
On competitive standing for Medicare, the provider is a major national-level contributor for key retina services: J0178 ranks #111 of 3204 providers nationally (97th percentile; notably above typical national volume) and 92134 ranks #269 of 26868 providers nationally (99th percentile; extreme outlier), reflecting unusually high volumes of aflibercept administration and retinal imaging compared with peers. Other top drug codes such as J2778 (rank #295 of 1208, 76th percentile) and J2777 (rank #1186 of 2039, 42th percentile) are more typical by national standards.
Medicaid revenues are also highly concentrated: the precomputed top 3 Medicaid codes account for 99.8% of Medicaid revenue, with J0178 representing 81.5% of Medicaid receipts, 67028 contributing 13.0%, and 92134 contributing 5.3%. Although the absolute Medicaid dollar amount is modest ($161K), the same injection- and imaging-focused service mix dominates Medicaid billing as it does Medicare.
In-state competitive positioning on Medicaid looks typical rather than dominant: J0178 ranks #39 of 101 providers in-state (62th percentile), 67028 ranks #93 of 262 (65th percentile), and 92134 ranks #206 of 728 (72th percentile). Those percentiles indicate consistent participation in Medicaid for retina services but not market leadership within the state for these codes.
Clinical versus cognitive care mix skews procedure- and drug-driven: evaluation and management and comprehensive exam codes such as 99214, 99213, and 92014 together account for only a small portion of Medicare revenue (each in the ~1.3% to 0.5% range individually), implying revenue is primarily generated by high-cost biologic administrations and imaging rather than office visit volume. This suggests operational emphasis on medication administration throughput, imaging capacity, and supply/biologic management.
Provider tenure supports an established retina practice: the NPI was enumerated 2012-04-09 (~14 years ago), indicating a stable period of billing history during which the high-volume patterns for J0178 and 92134 have been sustained. Combined with the concentrated revenue mix and national percentile standing on key codes, this tenure is consistent with a long-running retina specialty practice focused on intravitreal therapeutics and retinal imaging.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
21 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3,510 | $690 | $2.4M |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,470 | $180 | $265.3K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 7,860 | $30 | $227.9K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,960 | $90 | $176.2K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 3,340 | $30 | $96.8K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 570 | $120 | $68.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $90 | $45.9K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 520 | $90 | $45.1K |
| J3490 | Unclassified drugs | 30 | $1,780 | $44.5K |
| J3590 | Unclassified biologics | 20 | $1,770 | $42.4K |
Showing 1–10 of 21
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
21 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 11 | 230 | 560 | $690 | $693K |
| J2777 | 56 | 120 | 7,740 | $30 | $364.9K |
| J2778 | 7 | 70 | 510 | $180 | $131.6K |
| J2781 | 16 | 40 | 520 | $120 | $75.1K |
| J3590 | 11 | 20 | 30 | $1,430 | $72.7K |
| 67028 | 22 | 300 | 400 | $100 | $65.9K |
| J3490 | 99 | 120 | 60 | $470 | $50.8K |
| 92014 | 419 | 2,220 | 160 | $100 | $29.3K |
| 67036 | 24 | 50 | 20 | $940 | $23.5K |
| 67042 | 5 | 40 | 20 | $1,030 | $22.7K |
Showing 1–10 of 21
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 430 | $310 | $131.4K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 780 | $30 | $20.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,220 | $10 | $8.5K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 50 | $10 | $380 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 39 | 100 | 280 | $650 | $369.9K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 93 | 260 | 420 | $70 | $65.6K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 1,195 | 1,490 | 340 | $40 | $48.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 206 | 730 | 370 | $20 | $30K |
Other providers in the same ZIP code as Patrick Oellers, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Laboratory Alliance Of Central New York, LLC | NY | Clinical Medical Laboratory | $2.6M | $10.6M |
| Syracuse Asc, LLC | NY | Ambulatory Surgical Clinic/Center | $5M | $1.8M |
| Digestive Disease Center Of Central New York, LLC | NY | Ambulatory Surgical Clinic/Center | $706K | $3.6M |
| Robert Dracker | NY | Pediatrics Physician | $1.1M | $56.8K |
| Joseph Housel | NY | Dermatology Physician | $1.1M | $0 |
| Richard Stankus | NY | Allergy & Immunology Physician | $58.2K | $347K |
| Sherwin Pollock | NY | Diagnostic Radiology Physician | $349.2K | $30.3K |
| Leslie Woodcock | NY | Ophthalmology Physician | $292.4K | $0 |
| Nedim Ruhotina | NY | Urology Physician | $237K | $850 |
| Gary Leavitt | NY | Diagnostic Radiology Physician | $209.5K | $790 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.